A randomized, multicenter, double-blind, phase iii study to evaluate the efficacy and safety of a combination therapy of montelukast and levocetirizine in patients with asthma and allergic rhinitis

JONG SOOK PARK,CHOON-SIK PARK,YOUNG JOO CHO,BYOUNG WHUI CHOI

Clinical Therapeutics（2018）

引用 23|浏览53

暂无评分

摘要

The fixed-dose combination of montelukast and levocetirizine was effective and safe in treating perennial allergic rhinitis in patients with asthma compared with montelukast alone. ClinicalTrials.gov identifier: NCT02552667.

查看译文

关键词

allergic rhinitis,asthma,clinical trial,fixed-dose combination,levocetirizine,montelukast

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要